Editas Medicine, Inc. Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Editas Medicine, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Editas Medicine, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$65.7M, a 30.9% decline year-over-year.
  • Editas Medicine, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$229M, a 9.52% decline year-over-year.
  • Editas Medicine, Inc. annual Operating Income (Loss) for 2023 was -$169M, a 25.1% increase from 2022.
  • Editas Medicine, Inc. annual Operating Income (Loss) for 2022 was -$226M, a 17% decline from 2021.
  • Editas Medicine, Inc. annual Operating Income (Loss) for 2021 was -$193M, a 43.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$169M +$56.8M +25.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$226M -$32.8M -17% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$193M -$58.3M -43.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$135M +$6.08M +4.32% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 -$141M -$27.2M -23.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$114M +$6.21M +5.18% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$120M -$22.7M -23.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$97.2M -$61.9M -175% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 -$35.3M -$22.6M -178% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 -$12.7M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.